• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人银屑病:来自全国银屑病基金会医学委员会。

Psoriasis in the elderly: from the Medical Board of the National Psoriasis Foundation.

机构信息

Department of Dermatology and Murdough Family Center for Psoriasis, University Hospitals Case Medical Center, Cleveland, Ohio.

Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania.

出版信息

J Am Acad Dermatol. 2011 Sep;65(3):537-545. doi: 10.1016/j.jaad.2010.05.014. Epub 2011 Apr 15.

DOI:10.1016/j.jaad.2010.05.014
PMID:21496950
Abstract

BACKGROUND

The continuous increase in the US population older than 65 years and the chronic course of psoriasis make management of psoriasis in the elderly an important health care problem.

OBJECTIVE

We sought to develop a treatment algorithm for patients with psoriasis who are older than 65 years.

METHODS

A systematic literature search for studies on elderly patients with psoriasis was performed using MEDLINE.

RESULTS

We summarize the available published data on therapeutic modalities used in the elderly. We suggest a treatment algorithm including topical medications as first-line treatment for limited disease, with phototherapy, systemic retinoids, methotrexate, and biologics as the first-line systemic treatments for patients with more extensive disease. Cyclosporine should only rarely be used as a second-line systemic treatment for extensive disease in elderly patients with psoriasis.

LIMITATIONS

Limited data are available regarding treatment modalities specifically for elderly patients with psoriasis.

CONCLUSION

Appropriate treatment for elderly patients with limited psoriasis includes topical corticosteroids, topical vitamin D analogues, and topical tazarotene. For appropriately monitored elderly patients who have psoriasis with extensive disease, phototherapy, acitretin, methotrexate, alefacept, etanercept, adalimumab, infliximab, and ustekinumab are first-line therapies that can generally be safely used. There remains a need for further research on the management of psoriasis in elderly patients with psoriasis.

摘要

背景

美国 65 岁以上人口不断增加,且银屑病病程慢性,这使得老年人银屑病的管理成为一个重要的医疗保健问题。

目的

我们旨在为 65 岁以上的银屑病患者制定治疗方案。

方法

使用 MEDLINE 对老年银屑病患者的研究进行了系统的文献检索。

结果

我们总结了现有关于老年人中使用的治疗方法的已发表数据。我们建议了一种治疗方案,包括局部药物治疗作为局限性疾病的一线治疗,光疗、全身类视黄醇、甲氨蝶呤和生物制剂作为广泛疾病患者的一线全身治疗。环孢素仅应很少作为老年广泛型银屑病患者的二线全身治疗。

局限性

关于专门针对老年银屑病患者的治疗方法的数据有限。

结论

对于局限性银屑病老年患者,适当的治疗包括局部皮质类固醇、局部维生素 D 类似物和局部他扎罗汀。对于经过适当监测的患有广泛疾病的老年银屑病患者,光疗、阿维 A、甲氨蝶呤、阿昔单抗、依那西普、阿达木单抗、英夫利昔单抗和乌司奴单抗是一线治疗方法,通常可以安全使用。对于老年银屑病患者的银屑病管理,仍需要进一步的研究。

相似文献

1
Psoriasis in the elderly: from the Medical Board of the National Psoriasis Foundation.老年人银屑病:来自全国银屑病基金会医学委员会。
J Am Acad Dermatol. 2011 Sep;65(3):537-545. doi: 10.1016/j.jaad.2010.05.014. Epub 2011 Apr 15.
2
Combining traditional agents and biologics for the treatment of psoriasis.联合使用传统药物和生物制剂治疗银屑病。
Semin Cutan Med Surg. 2005 Mar;24(1):37-45. doi: 10.1016/j.sder.2005.01.002.
3
Advancements in the treatment of psoriasis: role of biologic agents.银屑病治疗的进展:生物制剂的作用
J Manag Care Pharm. 2004 Jul-Aug;10(4):318-25. doi: 10.18553/jmcp.2004.10.4.318.
4
Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.将生物疗法与银屑病的其他全身治疗相结合:来自国家银屑病基金会医学委员会的循证、最佳实践建议。
JAMA Dermatol. 2015 Apr;151(4):432-8. doi: 10.1001/jamadermatol.2014.3456.
5
Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting.在临床实践中常用的全身治疗或光疗对中度至重度斑块状银屑病的比较疗效。
Arch Dermatol. 2012 Apr;148(4):487-94. doi: 10.1001/archdermatol.2012.370.
6
Biologic drug survival in Israeli psoriasis patients.以色列银屑病患者的生物药物存活情况。
J Am Acad Dermatol. 2017 Apr;76(4):662-669.e1. doi: 10.1016/j.jaad.2016.10.033. Epub 2016 Dec 28.
7
Systemic Treatment of Recalcitrant Pediatric Psoriasis: A Case Series and Literature Review.儿童顽固性银屑病的系统治疗:病例系列及文献综述
J Drugs Dermatol. 2015 Aug;14(8):881-6.
8
Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.生物疗法和传统全身疗法在中重度银屑病老年和成年患者中显示出相似的安全性和疗效。
J Drugs Dermatol. 2015 Aug;14(8):846-52.
9
Treatment of psoriasis and psoriatic arthritis.治疗银屑病和银屑病关节炎。
BioDrugs. 2013 Jan;27 Suppl 1:3-12. doi: 10.1007/BF03325637.
10
[New systemic treatments for psoriasis: etanercept, infliximab, adalimumab, efalizumab and alefacept].银屑病的新型全身治疗方法:依那西普、英夫利昔单抗、阿达木单抗、依法利珠单抗和阿法赛特
Ned Tijdschr Geneeskd. 2006 May 13;150(19):1065-70.

引用本文的文献

1
Clinical characterization, physical frailty, and depression in elderly patients with psoriasis from a reference center in Brazil: a cross-sectional study.巴西参考中心老年银屑病患者的临床特征、身体虚弱和抑郁:一项横断面研究。
An Bras Dermatol. 2024 Jan-Feb;99(1):19-26. doi: 10.1016/j.abd.2023.01.001. Epub 2023 Aug 21.
2
Therapy of PsO in Special Subsets of Patients.特殊患者亚组中银屑病的治疗。
Biomedicines. 2022 Nov 10;10(11):2879. doi: 10.3390/biomedicines10112879.
3
Medicinal Treatment of Elderly Psoriasis Patients before and after Entering a Nursing Home.
老年银屑病患者入住养老院前后的药物治疗
Healthcare (Basel). 2022 Sep 8;10(9):1730. doi: 10.3390/healthcare10091730.
4
Drug Survival, Safety, and Effectiveness of Biologics in Older Patients with Psoriasis: A Comparison with Younger Patients-A BioCAPTURE Registry Study.生物制剂在老年银屑病患者中的生存、安全性和有效性:与年轻患者的比较——一项 BioCAPTURE 登记研究。
Drugs Aging. 2022 Sep;39(9):715-727. doi: 10.1007/s40266-022-00961-y. Epub 2022 Jul 21.
5
Health services in older psoriasis patients before and after nursing home admission : A retrospective analysis of health insurance data.老年银屑病患者在入住养老院前后的医疗服务:医疗保险数据的回顾性分析。
Z Gerontol Geriatr. 2023 Mar;56(2):139-145. doi: 10.1007/s00391-022-02020-y. Epub 2022 Mar 21.
6
Anti-interleukin-23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real-world practice.老年银屑病患者的抗白细胞介素-23 治疗:真实世界中 Guselkumab、Risankizumab 和 Tildrakizumab 的应用。
Clin Exp Dermatol. 2022 Mar;47(3):561-567. doi: 10.1111/ced.14979. Epub 2021 Nov 17.
7
Disease and Treatment Characteristics in Geriatric Psoriasis: A Patient Survey Comparing Age Groups.老年银屑病的疾病与治疗特征:一项比较年龄组的患者调查
Acta Derm Venereol. 2020 Jul 28;100(14):adv00215. doi: 10.2340/00015555-3569.
8
Management of inflammatory rheumatic conditions in the elderly.老年炎性风湿性疾病的管理。
Rheumatology (Oxford). 2019 May 1;58(5):748-764. doi: 10.1093/rheumatology/key165.
9
Managing Mild-to-Moderate Psoriasis in Elderly Patients: Role of Topical Treatments.老年患者中轻度至中度银屑病的管理:局部治疗的作用
Drugs Aging. 2017 Aug;34(8):583-588. doi: 10.1007/s40266-017-0480-8.
10
Biologic therapy adherence, discontinuation, switching, and restarting among patients with psoriasis in the US Medicare population.美国医疗保险人群中银屑病患者的生物治疗依从性、停药、换药及重新开始治疗情况。
J Am Acad Dermatol. 2016 Jun;74(6):1057-1065.e4. doi: 10.1016/j.jaad.2016.01.048. Epub 2016 Mar 4.